CTIC logo

CTI BioPharma (CTIC) Short Term Debt

Annual Short Term Debt

$48.72 M
+$184.00 K+0.38%

December 31, 2022

Summary

Performance

1-Year Change

+0.38%

3-Year Change

+912.55%

5-Year Change

+10873.87%

15-Year Change

+10873.87%

CTIC Short Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$48.72 M
CTIC annual short term debt is currently at an all-time high

3-Year Low

$48.54 M
CTIC annual short term debt is currently +0.38% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
CTIC previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
CTIC next annual earnings announcement has not yet been scheduled

OtherCTICbalance sheetmetrics:

Annual Total Liabilities

$143.50 M
CTIC annual total liabilities is $143.50 million

Annual Current Liabilities

$81.13 M
CTIC annual total current liabilities is $81.13 million

Annual Total Assets

$125.92 M
CTIC annual total assets is $125.92 million

Annual Current Assets

$99.40 M
CTIC annual total current assets is $99.40 million

Quarterly Short Term Debt

$48.90 M
+$171.00 K+0.35%

March 31, 2023

Summary

Performance

3-Month Change

+0.35%

1-Year Change

+1.14%

3-Year Change

+916.11%

5-Year Change

+3786.72%

CTIC Quarterly Short Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$57.88 M
CTIC quarterly short term debt is currently -15.52% below its historical high of $57.88 million

3-Year Low

$48.34 M
CTIC quarterly short term debt is currently +1.14% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2023
CTIC previous earnings announcement was published on Mar 31, 2023

Next Quarterly Earnings Report Date

N/A
CTIC next earnings announcement has not yet been scheduled

OtherCTICbalance sheetmetrics:

Quarterly Total Liabilities

$137.62 M
CTIC quarterly total liabilities is $137.62 million

Quarterly Current Liabilities

$68.23 M
CTIC quarterly total current liabilities is $68.23 million

Quarterly Total Assets

$112.27 M
CTIC quarterly total assets is $112.27 million

Quarterly Current Assets

$86.45 M
CTIC quarterly total current assets is $86.45 million

Short Term Debt Formula

Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings

CTIC Short Term Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+0.4%+1.1%
3 y3 years+912.5%+916.1%
5 y5 years+10000.0%+3786.7%

CTIC Short Term Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high-0.4%at high-1.1%
5 y5-yearat high-90.1%at high-91.8%
alltimeall timeat high-99.1%-15.5%-99.1%

CTI BioPharma Short Term Debt History

DateAnnualQuarterly
Mar 2023
-
$48.90 M(+0.4%)
Dec 2022
$48.72 M(+0.4%)
$48.72 M(+0.8%)
Mar 2022
-
$48.34 M(-0.4%)
Dec 2021
$48.54 M(+630.0%)
$48.54 M(-0.2%)
Sep 2021
-
$48.62 M(+1118.5%)
Jun 2021
-
$3.99 M(-27.8%)
Mar 2021
-
$5.53 M(-16.8%)
Dec 2020
$6.65 M(+38.2%)
$6.65 M(+17.5%)
Sep 2020
-
$5.66 M(+17.6%)
Jun 2020
-
$4.81 M(0.0%)
Mar 2020
-
$4.81 M(0.0%)
Dec 2019
$4.81 M(0.0%)
$4.81 M(-54.0%)
Sep 2019
-
$10.47 M(+117.6%)
Jun 2019
-
$4.81 M(0.0%)
Mar 2019
-
$4.81 M(0.0%)
Dec 2018
$4.81 M(+983.8%)
$4.81 M(+22.7%)
Sep 2018
-
$3.92 M(+51.5%)
Jun 2018
-
$2.59 M(+105.9%)
Mar 2018
-
$1.26 M(+183.3%)
Dec 2017
$444.00 K(-94.4%)
$444.00 K(-94.3%)
Sep 2017
-
$7.77 M(-7.8%)
Jun 2017
-
$8.42 M(+3.0%)
Mar 2017
-
$8.17 M(+2.8%)
Dec 2016
$7.95 M(-78.7%)
$7.95 M(+3.0%)
Sep 2016
-
$7.72 M(+2.9%)
Jun 2016
-
$7.50 M(+2.9%)
Mar 2016
-
$7.29 M(-80.5%)
Dec 2015
$37.37 M(+314.6%)
$37.37 M(+769.1%)
Sep 2015
-
$4.30 M(+52.3%)
Jun 2015
-
$2.82 M(-69.6%)
Mar 2015
-
$9.29 M(+3.1%)
Dec 2014
$9.01 M(+185.7%)
$9.01 M(+53.7%)
Sep 2014
-
$5.87 M(+41.3%)
Jun 2014
-
$4.15 M(+64.3%)
Mar 2014
-
$2.53 M(-19.9%)
Dec 2013
$3.15 M(-85.9%)
$3.15 M(+159.5%)
Sep 2013
-
$1.22 M(+158.2%)
Jun 2013
-
$471.00 K(-96.2%)
Sep 2011
-
$12.43 M(+0.9%)
Jun 2011
-
$12.31 M(-45.1%)
Mar 2011
-
$22.45 M(+0.6%)
Dec 2010
$22.31 M(-46.5%)
$22.31 M(+102.8%)
Sep 2010
-
$11.00 M(-77.8%)
Jun 2010
-
$49.46 M(+18.9%)
Mar 2010
-
$41.58 M(-0.2%)
Dec 2009
$41.67 M(+5405.3%)
$41.67 M(+2689.5%)
Sep 2009
-
$1.49 M(-4.2%)
Jun 2009
-
$1.56 M(-0.6%)
Mar 2009
-
$1.57 M(+107.4%)
DateAnnualQuarterly
Dec 2008
$757.00 K(-96.4%)
$757.00 K(+3.7%)
Sep 2008
-
$730.00 K(-0.8%)
Jun 2008
-
$736.00 K(-93.6%)
Mar 2008
-
$11.54 M(-44.6%)
Dec 2007
$20.84 M(+640.0%)
$20.84 M(-63.8%)
Sep 2007
-
$57.59 M(-0.5%)
Jun 2007
-
$57.88 M(+2146.9%)
Mar 2007
-
$2.58 M(-8.5%)
Dec 2006
$2.82 M(-71.2%)
$2.82 M(+4.3%)
Sep 2006
-
$2.70 M(+0.3%)
Jun 2006
-
$2.69 M(-68.2%)
Mar 2006
-
$8.46 M(-13.5%)
Dec 2005
$9.78 M(+607.7%)
$9.78 M(+212.4%)
Sep 2005
-
$3.13 M(+205.8%)
Jun 2005
-
$1.02 M(-15.2%)
Mar 2005
-
$1.21 M(-12.7%)
Dec 2004
$1.38 M(-21.7%)
$1.38 M(-7.3%)
Sep 2004
-
$1.49 M(-10.3%)
Jun 2004
-
$1.66 M(-7.6%)
Mar 2004
-
$1.80 M(+1.8%)
Dec 2003
$1.77 M(-21.5%)
$1.77 M(-3.5%)
Sep 2003
-
$1.83 M(-20.3%)
Jun 2003
-
$2.30 M(+1.4%)
Mar 2003
-
$2.27 M(+0.7%)
Dec 2002
$2.25 M(+9.7%)
$2.25 M(+35.8%)
Sep 2002
-
$1.66 M(+5.1%)
Jun 2002
-
$1.58 M(+18.4%)
Mar 2002
-
$1.33 M(-35.1%)
Dec 2001
$2.05 M(+36.7%)
$2.05 M(+46.0%)
Sep 2001
-
$1.41 M(+6.7%)
Jun 2001
-
$1.32 M(-6.6%)
Mar 2001
-
$1.41 M(-6.0%)
Dec 2000
$1.50 M(+36.4%)
$1.50 M(-17.6%)
Sep 2000
-
$1.82 M(+8.1%)
Jun 2000
-
$1.68 M(+34.4%)
Mar 2000
-
$1.25 M(+13.9%)
Dec 1999
$1.10 M(-8.3%)
$1.10 M(0.0%)
Sep 1999
-
$1.10 M(0.0%)
Jun 1999
-
$1.10 M(-8.3%)
Mar 1999
-
$1.20 M(0.0%)
Dec 1998
$1.20 M(-29.4%)
$1.20 M(-7.7%)
Sep 1998
-
$1.30 M(+18.2%)
Jun 1998
-
$1.10 M(-21.4%)
Mar 1998
-
$1.40 M(-17.6%)
Dec 1997
$1.70 M(+41.7%)
$1.70 M(+30.8%)
Sep 1997
-
$1.30 M(0.0%)
Jun 1997
-
$1.30 M(+8.3%)
Mar 1997
-
$1.20 M
Dec 1996
$1.20 M
-

FAQ

  • What is CTI BioPharma annual short term debt?
  • What is the all time high annual short term debt for CTI BioPharma?
  • What is CTI BioPharma annual short term debt year-on-year change?
  • What is CTI BioPharma quarterly short term debt?
  • What is the all time high quarterly short term debt for CTI BioPharma?
  • What is CTI BioPharma quarterly short term debt year-on-year change?

What is CTI BioPharma annual short term debt?

The current annual short term debt of CTIC is $48.72 M

What is the all time high annual short term debt for CTI BioPharma?

CTI BioPharma all-time high annual short term debt is $48.72 M

What is CTI BioPharma annual short term debt year-on-year change?

Over the past year, CTIC annual short term debt has changed by +$184.00 K (+0.38%)

What is CTI BioPharma quarterly short term debt?

The current quarterly short term debt of CTIC is $48.90 M

What is the all time high quarterly short term debt for CTI BioPharma?

CTI BioPharma all-time high quarterly short term debt is $57.88 M

What is CTI BioPharma quarterly short term debt year-on-year change?

Over the past year, CTIC quarterly short term debt has changed by +$552.00 K (+1.14%)